Aldosterone and the Metabolic Syndrome

NCT01103245 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders

Interventions

DRUG: Hydrochlorothiazide (HCTZ)
DRUG: Aliskiren 150 mg (ALI 150)
DRUG: Spironolactone (SPL 25)
DRUG: Aliskiren 300 mg (ALI 300)
DRUG: Spironolactone 50 mg (SPL 50)

Sponsor

Vanderbilt University Medical Center